Tag: India
Emcure Pharmaceuticals conferred with Merit Award at HIV Congress 2023
The Merit Award acknowledges the firm’s immense contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS
Apollo’s annual report lays thrust on preventive health, calls it a...
The hospital group has unveiled its annual report - Health of the Nation 2023, highlighting the prevalence and growth of NCDs in India
World Health Day: Thyrocare unveils ‘JAANCH’ specialized tailor-made health packages
The launch of Jaanch comes at a time when lifestyle diseases are becoming increasingly prevalent in India, contributing to around 60% of deaths
Thalassemics India celebrates 35 years of service
The event was graced to award doctors, patient achievers and caregivers who have worked tirelessly in the field of Thalassemia across the country recognizing them for their achievements
Amrita Hospital, Faridabad hosts preceptorship programme on Lymphoma for newly graduated...
The two-day programme was held to enhance the clinical learning and development of 30 young doctors who got an opportunity to know more about Lymphoma from top oncologists in India and abroad
Merck India organizes its first-ever student engagement programme in Bengaluru
Merck’s IT Centre engaged with students to understand their expectations from their future workforce
Aster DM Healthcare appoints Dr Nitish Shetty as India CEO
A seasoned healthcare management professional, Dr Nitish Shetty comes with close to two decades of leadership experience across various hospital chains
Eli Lilly forays into dermatological space, launches psoriasis drug Copellor in...
Post approval from the Drugs Controller General of India, the drug will be available for treatment of adults with moderate-to-severe plaque psoriasis
Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
In the last two years alone, the group has witnessed over 400% increase in the number of robotic-assisted procedures performed across its hospitals in India
Pfizer acquires Seagen for US$ 43 billion to develop better cancer...
Proposed combination enhances Pfizer’s position as a leading company in oncology